Dr. Harvey R. Samowitz, MD

Dr. Samowitz practices at HCA Florida Aventura Hospital in Miami, Florida.

Dr. Samowitz's NPI, 1477518082, was assigned on April 18, 2006. Dr. Samowitz graduated from Uconn School Of Medicine in 1984. Dr. Samowitz holds Florida license ME62933.

Dr. Samowitz's primary practice is HCA Florida Aventura Hospital, at 20900 Biscayne Blvd, Miami, FL 33180 in Miami-Dade County. The practice phone is (305) 682-7000.

Dr. Samowitz's primary practice is HCA Florida Aventura Hospital in Miami, Florida. Dr. Samowitz is also affiliated with Holmes Regional Medical Center. The medical group on file is Health First Medical Group (Formerly Mima). Dmand AI also links Dr. Samowitz to 3 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Samowitz practices, 5 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Samowitz's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Samowitz is board certified in female pelvic medicine and reconstructive surgery by the American Board of Urology. Dmand AI has Dr. Samowitz's licenses on file in 4 states: Florida, California, New Jersey and Illinois.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and pelvic prolapse among the conditions Dr. Samowitz treats.

CMS data shows 788 Medicare services from Dr. Samowitz across 9 procedure codes in 2024, for 193 Medicare patients. Medicare paid $37,253 for them.

CMS counts 193 Medicare patients who saw Dr. Samowitz in 2024. The largest group is 75 to 84, with 77 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Samowitz's median patient age at 69, with 33% women.

In 2024, Dr. Samowitz wrote 1,218 Medicare Part D claims for 360 patients. 83% of them were for generic drugs. CMS names the drug for 1,092 of them, across 24 drugs with 11 or more claims each, at $461,163 in total drug cost. In 2023, CMS named 1,327 claims across 24 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Samowitz for performance year 2024, reported individually. Dr. Samowitz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Samowitz.

CMS Open Payments shows 403 general payments to Dr. Samowitz from 48 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 60% of the total. Coloplast Corp paid the most, $3,219. It also lists 6 research payments totaling $460 in 2019.

Dmand AI lists 11 awards for Dr. Samowitz, most recently Clinical Associate Professor in 2012.

Dr. Samowitz graduated from Uconn School Of Medicine in 1984. Dr. Samowitz is a member of ACS, ASRM, AUA and Society for Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (SUFU).

Dr. Samowitz is in network with 9 carriers, including Aetna, Cigna and United Healthcare. HMO plans come from the most carriers, 6. Check the plan with the practice before a visit.